Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 80,686	$ 84,902
Advance payment on research contract	48,912	48,912
Prepaid expenses, including current portion of long-term prepaid insurance of $14,945 at September 30, 2018 and December 31, 2017	67,137	42,897
Total current assets	196,735	176,711
Long-term prepaid insurance, net of current portion of $14,945 at September 30, 2018 and December 31, 2017	6,850	18,059
Total assets	203,585	194,770
Current liabilities:
Accounts payable and accrued expenses, including $364,837 and $228,939 payable to related parties at September 30, 2018 and December 31, 2017, respectively	3,254,290	2,922,013
Accrued compensation and related expenses	1,115,800	479,300
Convertible notes payable, currently due and payable on demand, including accrued interest of $57,647 and $98,646 at September 30, 2018 and December 31, 2017, respectively (Note 4)	182,647	374,646
Note payable to SY Corporation, including accrued interest of $303,216 and $267,335 at September 30, 2018 and December 31, 2017, respectively (payment obligation currently in default – Note 4)	728,290	583,827
Notes payable to officers, including accrued interest of $45,808 and $26,538 as of September 30, 2018 and December 31, 2017, respectively (Note 4)	251,009	181,738
Other short-term notes payable	30,703	8,630
Total current liabilities	5,562,739	4,550,154
Commitments and contingencies (Note 8)
Stockholders’' deficiency: (Note 6)
Series B convertible preferred stock, $0.001 par value; $0.6667 per share liquidation preference; aggregate liquidation preference $25,001; shares authorized: 37,500; shares issued and outstanding: 11 common shares issuable upon conversion at 0.00030 common shares per Series B share	21,703	21,703
Common stock, $0.001 par value; shares authorized: 65,000,000; shares issued and outstanding: 3,588,433 and 3,065,261 at September 30, 2018 and December 31, 2017, respectively (Note 2)	3,588	3,065
Additional paid-in capital	158,335,634	157,422,110
Accumulated deficit	(163,720,079)	(161,802,262)
Total stockholders'’ deficiency	(5,359,154)	(4,355,384)
Total liabilities and stockholders'’ deficiency	$ 203,585	$ 194,770